about
Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI geneDimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysisTargeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasisCreating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug designThe current status of coagulationOptimal management of an aneurysmal subarachnoid hemorrhage in a patient with known factor XI deficiency: a case report.Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.Factor XI deficiency and its management.Coagulation factor XI deficiency in Holstein cattle: expression and distribution of factor XI activityStructure and function of factor XICurrent therapy for rare factor deficiencies.Autosomal recessive deficiencies of coagulation factors.Rare coagulation deficiencies.Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitorsA novel missense mutation Asp506Gly in Exon 13 of the F11 gene in an asymptomatic Korean woman with mild factor XI deficiency.Contact pathway of coagulation and inflammationPolyphosphate is a cofactor for the activation of factor XI by thrombin.Blood clot formation under flow: the importance of factor XI depends strongly on platelet count.A classification system for cross-reactive material-negative factor XI deficiencyGynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsisTherapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency.Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing studyExosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?Inherited factor XI deficiency: a concise review.Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XICharacterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.Why factor XI deficiency is a clinical concern.Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis.Antisense technology: an emerging platform for cardiovascular disease therapeutics.Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2).Coagulation factor XI as a novel target for antithrombotic treatment.Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.Factor XII: a novel target for safe prevention of thrombosis and inflammation.Preoperative management of factor XI deficiency with therapeutic plasma exchange: A case report and literature review.Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factorComprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.
P2860
Q24318272-E830D12C-D6DF-45A5-816E-D953C4D783F8Q24680521-797C7A37-43A3-45F4-B01D-150DEABD25A6Q28508572-3A05732D-EC75-4896-936B-1889F2CD377DQ28543133-E8EAA381-C6E2-400B-A435-3A8505FC73BFQ28679165-DF5CB6B5-5D34-4BFB-ACC9-367BE9A4DCC0Q33312414-A7D138C6-A9E3-4678-B0CB-32A49235F49CQ33934481-EEC907BA-6D72-41CB-A8B2-493DB4ABDB49Q34029498-37936590-9B08-4E2E-A3E6-18F69F6768C3Q34094899-94BF570D-5081-4AC0-8148-7705840AABF2Q34095400-DC71CC50-F51D-430D-8D2A-C5DA4C8CE313Q34176021-AC415EDB-6ABB-4E5B-8EE0-92608A0274FDQ34530397-452633A0-10B8-423D-81AA-2FC87DD1407AQ34637015-0DE6E473-014E-4FD2-B38C-ACDEFB8F3E50Q35049040-D0FC86EE-092E-4C21-9B9E-2308924F0E53Q35300353-91AE2B12-8EE8-410B-B0DF-2112BC473E18Q35575101-1857EF9A-EE1B-4E9E-AEDF-C3A062E80BEFQ35631344-42E70793-67FF-4A54-9729-6BDFECE3D46CQ35649582-2267918A-5178-40F6-8F61-8AAEB20C7635Q35847443-9381A60F-6E29-404F-9928-209FA2E243DEQ35860500-EFF890FA-E010-4759-BE55-31DD587F4F09Q36010211-E42E72EB-B7E4-4B40-8FD6-C11134851316Q36308588-F6A7784F-3768-406C-9A53-224EADC75010Q36311332-C8057B43-0FB8-4880-9C70-72DEB1F5F6FAQ36538521-D95A7BB9-0A04-4AB5-AA78-0970C8EB3712Q36606627-FA1C8C62-4A48-4735-99ED-9445A7AE5805Q36868584-F7D825C5-DFCE-472A-888D-08BE150FB153Q37071138-4236D780-D611-4BAC-A271-0FB1E3B56394Q37078887-0084445B-8D75-46D3-8E9F-C862BC9DC05EQ37108888-14E9BA4F-8CB7-48D4-B07B-5CCB04708BACQ37124827-F4C5E10C-B324-4654-A3B8-92D02AAA5E70Q37337608-9E42AF0F-9810-460E-B227-8F959CD188ECQ37374500-BABB7705-947E-40EA-BDE1-CDCE9FFF45A3Q37781402-A95FAB8A-0C5C-415C-9F9B-F2771E9771CFQ38378483-27FE493A-DA66-499F-A8C9-E589945D5976Q38412212-A01211DA-1D01-4030-A6AF-2535D4B7E7E0Q38587540-C962A2DD-E401-419B-AAEF-B187C8313A43Q38673467-2E538735-8C31-46D2-811E-4272EF413B77Q39784189-7E2AF1E0-01D5-494F-BB78-386A4A4F79B2Q39796241-1BEE0DBC-8545-4DD4-81C7-42B57AA75DF2Q40454479-FECD8972-D8D3-42E5-B55F-6899D5BCE8DA
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Factor XI deficiency in Ashkenazi Jews in Israel.
@ast
Factor XI deficiency in Ashkenazi Jews in Israel.
@en
Factor XI deficiency in Ashkenazi Jews in Israel.
@nl
type
label
Factor XI deficiency in Ashkenazi Jews in Israel.
@ast
Factor XI deficiency in Ashkenazi Jews in Israel.
@en
Factor XI deficiency in Ashkenazi Jews in Israel.
@nl
prefLabel
Factor XI deficiency in Ashkenazi Jews in Israel.
@ast
Factor XI deficiency in Ashkenazi Jews in Israel.
@en
Factor XI deficiency in Ashkenazi Jews in Israel.
@nl
P2093
P1476
Factor XI deficiency in Ashkenazi Jews in Israel.
@en
P2093
P304
P356
10.1056/NEJM199107183250303
P407
P577
1991-07-01T00:00:00Z